LeadSynBio completes 450 million yuan Pre-IPO financing

Recently, Leading Biology completed a 450 million yuan Pre-IPO financing round, which was jointly subscribed by new and existing investors. The funds raised will be focused on new product R&D and industrialization, stepping up market expansion efforts, and comprehensively enhancing the company's overall competitiveness.